Magnetar Financial LLC Acquires Shares of 26,407 Henry Schein, Inc. $HSIC

Key Points

• Magnetar Financial LLC acquired 26,407 shares of Henry Schein, Inc. for approximately $1.81 million in the first quarter.
• Henry Schein reported $1.10 earnings per share (EPS) for the last quarter, missing estimates by $0.09, with revenues of $3.24 billion.
• Analysts have set a consensus target price of $76.67 for Henry Schein, with five analysts rating the stock as a Buy and seven as a Hold.

Magnetar Financial LLC acquired a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 26,407 shares of the company's stock, valued at approximately $1,809,000.

Other institutional investors have also recently added to or reduced their stakes in the company. State of Wyoming raised its position in Henry Schein by 205.1% in the first quarter. State of Wyoming now owns 11,335 shares of the company's stock valued at $776,000 after purchasing an additional 7,620 shares during the period. Trexquant Investment LP raised its position in Henry Schein by 27.3% in the first quarter. Trexquant Investment LP now owns 11,213 shares of the company's stock valued at $768,000 after purchasing an additional 2,403 shares during the period. Zuckerman Investment Group LLC raised its position in Henry Schein by 69.6% in the first quarter. Zuckerman Investment Group LLC now owns 201,639 shares of the company's stock valued at $13,810,000 after purchasing an additional 82,779 shares during the period. Gamco Investors INC. ET AL raised its position in Henry Schein by 2.0% in the first quarter. Gamco Investors INC. ET AL now owns 354,970 shares of the company's stock valued at $24,312,000 after purchasing an additional 6,892 shares during the period. Finally, FORA Capital LLC purchased a new stake in Henry Schein in the first quarter valued at $785,000. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Stock Down 1.8%

Shares of NASDAQ:HSIC traded down $1.26 on Wednesday, hitting $67.13. 1,450,161 shares of the company's stock were exchanged, compared to its average volume of 1,758,147. The firm's 50-day moving average is $70.22 and its 200 day moving average is $69.93. The company has a market capitalization of $8.14 billion, a PE ratio of 21.65, a P/E/G ratio of 2.30 and a beta of 0.86. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The business had revenue of $3.24 billion for the quarter, compared to analyst estimates of $3.22 billion. During the same period in the prior year, the company posted $1.23 earnings per share. The company's revenue was up 3.3% compared to the same quarter last year. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Sell-side analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Wall Street Analysts Forecast Growth

HSIC has been the topic of a number of research analyst reports. UBS Group reduced their target price on Henry Schein from $75.00 to $70.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 6th. Wells Fargo & Company reduced their target price on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Stifel Nicolaus reiterated a "hold" rating and issued a $75.00 price objective (down previously from $80.00) on shares of Henry Schein in a report on Friday, July 25th. Leerink Partners set a $75.00 price objective on Henry Schein in a report on Monday, July 14th. Finally, JPMorgan Chase & Co. cut their price objective on Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a report on Thursday, August 7th. Five investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $76.67.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.